BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Tomohiro Tanaka, Nobuhisa Akamatsu, Junichi Kaneko, Junichi Arita, Sumihito Tamura, Kiyoshi Hasegawa, Yoshihiro Sakamoto, Norihiro Kokudo. Daclatasvir and asunaprevir for recurrent hepatitis C following living donor liver transplantation with HIV co-infectionHepatology Research 2016; 46(8): 829 doi: 10.1111/hepr.12614
2
José Castellote, Francisco Gea, Luis Enrique Morano, Rosa M. Morillas, Juan Antonio Pineda, Mercedes Vergara, María Buti. Factores que influyen en la curación de la hepatitis C en la era de los antivirales de acción directaGastroenterología y Hepatología 2019; 42: 1 doi: 10.1016/S0210-5705(20)30181-3
3
Aurélie Barrail-Tran, Lauriane Goldwirt, Thibaut Gelé, Claire Laforest, Audrey Lavenu, Hélène Danjou, Sylvie Radenne, Vincent Leroy, Pauline Houssel-Debry, Christophe Duvoux, Nassim Kamar, Victor De Ledinghen, Valérie Canva, Filomena Conti, François Durand, Louis D’Alteroche, Danielle Botta-Fridlund, Christophe Moreno, Carole Cagnot, Didier Samuel, Claire Fougerou-Leurent, Georges-Philippe Pageaux, Jean-Charles Duclos-Vallée, Anne-Marie Taburet, Audrey Coilly. Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohortEuropean Journal of Clinical Pharmacology 2019; 75(11): 1555 doi: 10.1007/s00228-019-02725-x
4
G. Sanchez Antolin, M. Testillano, J.M. Pascasio, I. Narvaez Rodriguez, M. Prieto, A. Otero, J.I. Herrero, M. Londoño, I. Fernandez Vazquez, L. Castells, Xavier Xiol, Maria Luisa Gonzalez Dieguez, Mario Romero Cristobal, Jose Antonio Pons Miñano, Sonia Pascual Bartolome, Jose Luis Montero, Ana Arencibia, Sara Lorente, Esther Molina, Maria Dolores Espinosa, Valentin Cuervas-Mons, Emilio Fabrega Garcia. Efficacy and Safety of Therapy With Simeprevir and Sofosbuvir in Liver Transplant Recipients Infected by Hepatitis C Virus Genotype 4: Cohort Spanish Society of Liver Transplantation CohortTransplantation Proceedings 2016; 48(9): 3013 doi: 10.1016/j.transproceed.2016.08.034
5
Xiaobo Zhu, Mingqi Wang, Mei Liu, Xinghao Yu, Peng Huang. Efficacy and safety of direct-acting antivirals for treatment-naive patients with genotype 1 hepatitis C virus infectionPersonalized Medicine 2019; 16(5): 421 doi: 10.2217/pme-2018-0121
6
B.-H. Jung, J.-I. Park, S.-G. Lee. Successful Treatment of Fibrosing Cholestatic Hepatitis With Daclatasvir and Asunaprevir After Liver Transplantation: A Case ReportTransplantation Proceedings 2018; 50(9): 2877 doi: 10.1016/j.transproceed.2018.03.057
7
Islam El-Garawani, Sobhy Hassab El-Nabi, Marwa Gadallah, Eman Abdelsameea. Association between IFN-λ 3 Gene Polymorphisms and Outcome of Treatment with Direct Acting Antivirals in Chronic HCV-Infected Egyptian PatientsImmunological Investigations 2020; : 1 doi: 10.1080/08820139.2020.1722158
8
Suresh Gorka, Ghulam M. Gulzar, Ghulam N. Yattoo, Jaswinder S. Sodhi, Gulzar A. Dar, Mushtaq A. Laway, Saurabh Kaushik, Neeraj Dhar, Syed Mushfiq, Riffat A. Aziz. Genotype 1 and 3 Response to Velpatasvir and Sofosbuvir in Chronic Hepatitis C in the Kashmiri Population: An Observational StudyJournal of Clinical and Experimental Hepatology 2020; 10(2): 155 doi: 10.1016/j.jceh.2019.07.003
9
T. Sauerbruch, B. Appenrodt. Therapie-Handbuch2018; : 446 doi: 10.1016/B978-3-437-24950-1.00057-3
10
Ewelina Krol, Gabriela Pastuch-Gawolek, Binay Chaubey, Gabriela Brzuska, Karol Erfurt, Boguslaw Szewczyk. Novel Uridine Glycoconjugates, Derivatives of 4-Aminophenyl 1-Thioglycosides, as Potential Antiviral CompoundsMolecules 2018; 23(6): 1435 doi: 10.3390/molecules23061435
11
Daniel Esteban Pino Marín, Pedro Amariles, Jaime Alberto Peláez Alvárez, Gloria Priscilla Alvárez Osorio, Juliana González Ceballos. Aproximación para establecer y evaluar la relevancia clínica de las interacciones medicamentosas en el tratamiento de pacientes infectados con virus de hepatitis C, revisión estructurada (actualización 2015 – 2017)Revista Colombiana de Gastroenterología 2019; 34(2): 159 doi: 10.22516/25007440.252
12
Aldo Bonaventura, Fabrizio Montecucco. Sofosbuvir/velpatasvir: A promising combinationWorld Journal of Hepatology 2016; 8(19): 785-789 doi: 10.4254/wjh.v8.i19.785
13
Tomohide Hori, Yasuharu Onishi, Hideya Kamei, Nobuhiko Kurata, Masatoshi Ishigami, Yoji Ishizu, Yasuhiro Ogura. Fibrosing Cholestatic Hepatitis in a Complicated Case of an Adult Recipient After Liver Transplantation: Diagnostic Findings and Therapeutic DilemmaAmerican Journal of Case Reports 2016; 17: 597 doi: 10.12659/AJCR.898427
14
A.E. Shafii, D.D. Harris, M. Baz. Clearance of Hepatitis C Virus Prior to Lung Transplantation: A Case ReportTransplantation Proceedings 2017; 49(7): 1682 doi: 10.1016/j.transproceed.2017.06.002
15
Sunil Taneja, Ajay Duseja, Arka De, Vivek Kumar, Raja Ramachandran, Ashish Sharma, Radha K Dhiman, Krishan L Gupta, Yogesh Chawla. Successful treatment of chronic hepatitis C infection with directly acting antivirals in renal transplant recipientsNephrology 2018; 23(9): 876 doi: 10.1111/nep.13109
16
Xavier Forns, Marina Berenguer, Kerstin Herzer, Martina Sterneck, Maria Francesca Donato, Pietro Andreone, Stefano Fagiuoli, Tomasz Cieciura, Magdalena Durlik, Jose Luis Calleja, Zoe Mariño, Umesh Shukla, Thierry Verbinnen, Oliver Lenz, Sivi Ouwerkerk-Mahadevan, Monika Peeters, Katrien Janssen, Ronald Kalmeijer, Wolfgang Jessner. Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN studyTransplant Infectious Disease 2017; 19(3): e12696 doi: 10.1111/tid.12696
17
N. Blank, H.-M. Lorenz. Kryoglobulinämische VaskulitidenZeitschrift für Rheumatologie 2016; 75(3): 303 doi: 10.1007/s00393-016-0076-4
18
Shinya Maekawa, Mitsuaki Sato, Natsuhiko Kuratomi, Taisuke Inoue, Yuichiro Suzuki, Akihisa Tatsumi, Mika Miura, Shuya Matsuda, Masaru Muraoka, Natsuko Nakakuki, Fumitake Amemiya, Shinichi Takano, Mitsuharu Fukasawa, Yasuhiro Nakayama, Tatsuya Yamaguchi, Tadashi Sato, Minoru Sakamoto, Miyako Murakawa, Mina Nakagawa, Yasuhiro Asahina, Nobuyuki Enomoto. Association between alanine aminotransferase elevation and UGT1A1*6 polymorphisms in daclatasvir and asunaprevir combination therapy for chronic hepatitis CJournal of Gastroenterology 2018; 53(6): 780 doi: 10.1007/s00535-017-1405-3
19
Kelly H. Schlendorf, Sandip Zalawadiya, Ashish S. Shah, Mark Wigger, Chan Y. Chung, Sarah Smith, Matthew Danter, Chun W. Choi, Mary E. Keebler, D. Marshall Brinkley, Suzanne Brown Sacks, Henry Ooi, Roman Perri, Joseph A. Awad, Samuel Lewis, Rachel Hayes, Heather O’Dell, Callie Darragh, Alicia Carver, Cori Edmonds, Shelley Ruzevich-Scholl, JoAnn Lindenfeld. Early outcomes using hepatitis C–positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapiesThe Journal of Heart and Lung Transplantation 2018; 37(6): 763 doi: 10.1016/j.healun.2018.01.1293
20
Kiyohiko Omichi, Nobuhisa Akamatsu, Kazuhiro Mori, Junichi Togashi, Junichi Arita, Junichi Kaneko, Kiyoshi Hasegawa, Yoshihiro Sakamoto, Norihiro Kokudo. Asunaprevir/daclatasvir and sofosbuvir/ledipasvir for recurrent hepatitis C following living donor liver transplantationHepatology Research 2017; 47(11): 1093 doi: 10.1111/hepr.12845